Xbrane Biopharma
Courtagefri handel på Nordnet till sista juni 2027! Har du inget konto på Nordnet så är det verkligen läge att skaffa ett. Just nu får nya kunder courtagefri handel till sista juni 2027. Läs mer om erbjudandet och skapa ditt konto här Erbjudandet gäller nya kunder och omfattar handel via Nordnets app eller hemsida i nordiska aktier, ETF:er, teckningsrätter och teckningsoptioner. För fullständiga villkor se nordnet.se/jubileum. Kom ihåg att investeringar alltid innebär en risk.
Siavash Bashiri sells shares to repay loan taken in connection with the 2024 rights issue, but remains a dedicated and long-term employee and shareholder
Xbrane Biopharma AB (publ) (“Xbrane” or “the Company”) (Nasdaq Stockholm: XBRANE) announces that Siavash Bashiri of Xbrane's management team have sold shares to pay back a loan that was taken in connection with the rights share issue in 2024 and which has matured. Siavash Bashiri has sold 14 733 shares and has a remaining ownership of 18 367 shares.
“The sale is made solely to repay the loan, and Siavash Bashiri’s remaining holdings in Xbrane are still by far his largest private financial investment. Siavashs commitment and strong belief in Xbrane’s future prospects remain,” says Martin Åmark, CEO of Xbrane.
| Datum | 2025-10-28, kl 21:00 |
| Källa | MFN |